Update on AllTrials campaign for publication of full research results: PhRMA unhappy but GSK sign up

1 April 2013. Related: Other news.

The previous issue of HTB included information about a new campaign calling for the publication of the results (that is, full clinical study reports including negative ones) from all clinical trials – past, present and future – on all treatments currently being used. [1]

Clearly unhappy, the US-based pharmaceutical membership and public relations organisation PhRMA has countered with a press statement from. [2]

It was timely that two days later GSK announced its support for the AllTrials campaign. [3]

References:

1. “AllTrials” campaign for publication of full research results. HTB January/February 2013.
   https://i-base.info/htb/20803
2. PhRMA press statement. PhRMA Statement on Clinical Trials and Bad Pharma. 4 February 2013.
   http://www.phrma.org/media/releases/phrma-statement-clinical-trials-bad-pharma
3. GSK press release. GSK announces support for AllTrials campaign for clinical data transparency. 5 February 2013.
   http://www.gsk.com/media/press-releases.html